BMY Bristol-Myers Squibb
Stock · NYSE · United States · Healthcare · US1101221083
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Bristol-Myers Squibb, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 06 Nov 2026 17:01. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 11 Jul 2022 – 15 Jul 2022 | 75.50 | 75.99 | 73.24 | 75.65 | +0.36% | 45,447,500 | |
| 05 Jul 2022 – 08 Jul 2022 | 76.37 | 77.10 | 74.63 | 75.38 | -1.90% | 42,252,600 | |
| 27 Jun 2022 – 01 Jul 2022 | 79.23 | 80.59 | 75.77 | 76.84 | -2.68% | 53,282,600 | 0.5400 |
| 21 Jun 2022 – 24 Jun 2022 | 75.00 | 79.00 | 74.52 | 78.96 | +7.04% | 51,277,600 | |
| 13 Jun 2022 – 17 Jun 2022 | 73.86 | 74.37 | 71.71 | 73.77 | -1.76% | 90,801,900 | |
| 06 Jun 2022 – 10 Jun 2022 | 75.45 | 76.98 | 74.69 | 75.09 | -0.11% | 55,888,200 | |
| 31 May 2022 – 03 Jun 2022 | 75.08 | 75.98 | 73.62 | 75.17 | -1.27% | 65,890,800 | |
| 23 May 2022 – 27 May 2022 | 76.51 | 78.61 | 75.47 | 76.14 | -0.07% | 67,634,600 | |
| 16 May 2022 – 20 May 2022 | 76.29 | 78.47 | 75.34 | 76.19 | +0.51% | 75,165,000 | |
| 09 May 2022 – 13 May 2022 | 75.69 | 77.33 | 74.86 | 75.80 | -1.13% | 78,149,800 | |
| 02 May 2022 – 06 May 2022 | 75.37 | 77.03 | 74.21 | 76.67 | +1.86% | 82,563,600 | |
| 25 Apr 2022 – 29 Apr 2022 | 75.74 | 77.75 | 73.35 | 75.27 | -0.63% | 86,959,300 | |
| 18 Apr 2022 – 22 Apr 2022 | 77.15 | 78.17 | 75.68 | 75.75 | -2.27% | 62,659,600 | |
| 11 Apr 2022 – 14 Apr 2022 | 77.70 | 78.13 | 75.57 | 77.51 | -0.33% | 54,848,500 | |
| 04 Apr 2022 – 08 Apr 2022 | 74.00 | 78.06 | 73.54 | 77.77 | +5.35% | 84,175,800 | |
| 28 Mar 2022 – 01 Apr 2022 | 73.20 | 74.07 | 72.66 | 73.82 | +0.74% | 67,280,700 | 0.5400 |
| 21 Mar 2022 – 25 Mar 2022 | 71.48 | 73.46 | 70.27 | 73.28 | +3.18% | 71,104,900 | |
| 14 Mar 2022 – 18 Mar 2022 | 68.93 | 71.02 | 68.75 | 71.02 | +3.12% | 99,398,700 | |
| 07 Mar 2022 – 11 Mar 2022 | 69.21 | 69.49 | 67.33 | 68.87 | -0.71% | 74,210,400 | |
| 28 Feb 2022 – 04 Mar 2022 | 67.69 | 69.65 | 67.29 | 69.36 | +0.81% | 76,710,300 | |
| 22 Feb 2022 – 25 Feb 2022 | 67.67 | 69.32 | 66.19 | 68.80 | +1.85% | 65,504,100 | |
| 14 Feb 2022 – 18 Feb 2022 | 66.87 | 68.39 | 65.82 | 67.55 | +1.00% | 79,900,200 | |
| 07 Feb 2022 – 11 Feb 2022 | 65.38 | 67.36 | 65.00 | 66.88 | +2.91% | 85,109,600 | |
| 31 Jan 2022 – 04 Feb 2022 | 64.58 | 65.45 | 62.90 | 64.99 | +0.12% | 63,544,800 | |
| 24 Jan 2022 – 28 Jan 2022 | 63.18 | 64.92 | 61.19 | 64.91 | +2.16% | 75,500,500 |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
Key data
- Previous close
- 63.13 USD
- Market cap
- 129.0B
- Dividend yield
- 3.99%
- 5-year average yield
- 3.86%
- Payout ratio
- 56%
- Last dividend
- 0.6300 USD · 02 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 02 Oct 2026 | 0.6300 USD |
| 02 Jul 2026 | 0.6300 USD |
| 02 Apr 2026 | 0.6300 USD |
| 02 Jan 2026 | 0.6300 USD |
| 03 Oct 2025 | 0.6200 USD |
| 03 Jul 2025 | 0.6200 USD |
| 04 Apr 2025 | 0.6200 USD |
| 03 Jan 2025 | 0.6200 USD |
| 04 Oct 2024 | 0.6000 USD |
| 05 Jul 2024 | 0.6000 USD |
| 04 Apr 2024 | 0.6000 USD |
| 04 Jan 2024 | 0.6000 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 16.6 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 23.1 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 7.4 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 10.0 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 9.1 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 2.4 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 14.07× | Good | 32.71× |
| P/E (forward) | 9.54× | Good | 15.76× |
| Price / book | 5.54× | Weak | 3.74× |
| Price / sales | 2.59× | Fair | 3.52× |
| EV / EBITDA | 8.96× | Good | 13.54× |
| Free cash flow yield | 4.9% | Fair | 3% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 70.5% | Good | 66.1% |
| Operating margin | 33.8% | Good | 8% |
| Net margin | 18.5% | Good | 3.5% |
| Return on equity | 44% | Good | 6.4% |
| Return on assets | 10.9% | Good | 3.9% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 1.4% | Weak | 10.5% |
| EPS growth / year | 5.5% | Fair | 7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.91× | Weak | 0.52× |
| Net debt / EBITDA | 1.77× | Fair | 1.62× |
| Interest cover | 7.26× | Fair | 3.3× |
| Current ratio | 1.59× | Good | 2.12× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 55.9% | Fair | 0% |
| Payout of free cash flow | 79.3% | Weak | 45% |
| Payout of free cash flow (3 years) | 37.2% | Good | — |
| Dividend growth / year | 4.7% | Fair | 7.1% |
| Years of rising dividends | 4 | Fair | 4.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow BMY and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.